S&P Futures
4,135.75+8.00(+0.19%)Dow Futures
33,729.00+20.00(+0.06%)Nasdaq Futures
13,769.50+19.25(+0.14%)
FibroGen, Inc. (FGEN)
21.12 0.00 (0.00%)
Pre-Market: 7:59AM EDT
Chart Events
Performance Outlook
| Previous Close | 21.06 |
| Open | 21.04 |
| Bid | 20.93 x 1000 |
| Ask | 0.00 x 1200 |
| Day's Range | 20.51 - 21.65 |
| 52 Week Range | 18.12 - 57.21 |
| Volume | 1,397,030 |
| Avg. Volume | 1,670,481 |
| Market Cap | 1.939B |
| Beta (5Y Monthly) | 1.19 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.11 |
| Earnings Date | May 04, 2021 - May 10, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 40.57 |
Fair Value
Related Research
- ACCESSWIRE
CLASS ACTION UPDATE for CYDY, FGEN and EBS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders
NEW YORK, NY / ACCESSWIRE / April 23, 2021 / Levi & Korsinsky, LLP announces that class action lawsuits have commenced on behalf of shareholders of the following publicly-traded companies. Shareholders interested in serving as lead plaintiff have until the deadlines listed to petition the court.
- Newsfile
FIBROGEN SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against FibroGen, Inc. - FGEN
New Orleans, Louisiana--(Newsfile Corp. - April 22, 2021) - Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until June 11, 2021 to file lead plaintiff applications in a securities class action lawsuit against FibroGen, Inc. (NASDAQ: FGEN), if they purchased the Company's securities and/or sold put options between November 8, 2019 and April 6, 2021, inclusive (the "Class Period"). ...
- Kessler Topaz Meltzer & Check, LLP Announces a Securities Fraud Class Action Lawsuit Filed Against Emergent BioSolutions Inc. (EBS)Business Wire
- SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in MultiPlan Corporation f/k/a Churchill Capital Corp. III of Class Action Lawsuit and Upcoming Deadline - MPLN; MPLN.WS; CCXX; CCXX.WS; CCXX.UNewsfile
- ACCESSWIRE
Investor Alert: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against FibroGen, Inc. (FGEN)
RADNOR, PA / ACCESSWIRE / April 22, 2021 / The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of FibroGen, Inc. (NASDAQ:FGEN) ("FibroGen") that a securities fraud class action lawsuit has been filed against on behalf of those who purchased or acquired FibroGen securities and/or sold put optionsfrom November 8, 2019 through April 6, 2021, inclusive (the "Class Period").
